Home » Topics » Articles » Insight

Insight
RSS

Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: June 2000

July 24, 2000

TKT In The Amgen Fight: 'Good Buy' or Goodbye?

July 24, 2000

AIDS Vaccine Race Holds Big Potential Along With Big Risk

July 17, 2000

Clinical Trial Update: June 2000

July 17, 2000

Public Financing of Biotechnology: June 2000

July 10, 2000

Other Financings Of Public Biotechnology Companies: June 2000

July 10, 2000

Venture Capital And Corporate Investments In Biotechnology Companies: June 2000

July 10, 2000

Boston U. Firm To Capitalize On Analyzing Public Heart Data

July 10, 2000

Celera's Accomplishment Puts 'Function' Back in Genomics

July 3, 2000

Biotech Corporate Collaborations in Agriculture: New Agreements Jan. 1 - June 30, 2000

July 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...